Case series reports 75.6% symptom reduction in patients with tinea corporis, suggesting Unani therapies may be effective.
Background: Tinea corporis, identified as Qubāʼ in Unani medicine, is a common superficial fungal infection. Classical Unani texts offer a holistic management framework, integrating principles of temperament (Mizāj), humoral balance, and both topical and systemic therapies. Objective: To evaluate the clinical efficacy of individualized Unani regimens in managing Qubāʼ through symptom monitoring and temperament-based selection of formulations. Methods: Five patients clinically diagnosed with Tinea corporis were treated at HSZH Unani Medical College & Hospital, Bhopal. Oral polyherbal formulations—Itrifāl Shahātra, Majoon Ushba, Habbe Musaffi, Dawā-e-Musaffi, or Arq Shahātra—were administered alongside the standard topical application of Marham-e-Qūba. Treatment duration was 28 days, with assessments on Day 1, 14, and 28 using the Dermatophytosis Symptom Score (DSS). Results: All patients demonstrated progressive improvement with a mean DSS reduction of 75.6% by Day28. Pruritus showed the most significant reduction (85.7%), followed by erythema (76.9%) and scaling (54.5%). The combination of Itrifāl Shahātra + Marham-e-Qūba was the most effective. No adverse events or recurrence were observed. Conclusion: This study highlights the clinical potential of Unani therapies in managing superficial fungal infections. The integration of temperament-based oral regimens and a standardized topical application showed marked symptom relief, safety, and patient satisfaction. Further controlled trials are recommended to validate these findings and expand therapeutic options in integrative dermatology.
No takes yet. Share an insight, caveat, or question.
Ansar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: